Takashi Koyama
Saitama Municipal Hospital, Japan
Biography
Dr. Koyama is currently a vice director of the Saitama Municipal Hospital in Saitama, Japan. He has expertise in research in myocardial reperfusion injury. He has recently developed a new treatment strategy for myocardial reperfusion injury in patients with ST-segment elevation myocardial infarction (STEMI), based on the results of his previous experimental study using guinea-pig myocytes that was published in Am J Physiol in 1991. He is basically a clinical cardiologist, performing percutaneous coronary intervention himself. But his experiences not only in STEMI treatment but also in animal experiments inspired him to develop a new treatment strategy for myocardial reperfusion injury, i.e. postconditioning with lactate-enriched blood. He has already published a review paper on this new approach in IJC Heart & Vasculature, claiming that the new approach may be effective against all four types of myocardial reperfusion injury.